Jennifer La PhD

Published on 6/2/2026

Lam BD, Ito S, Ryu J, O'Sullivan K, Potnis K, Lu R, Bidikian A, Ng DQ, Singh R, Deter A, Carfagnini C, Bechara S, Kandula M, Do N, Fillmore N, Freed JA, Patell R, La J, Goshua G. JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost-Effectiveness Analysis. Am J Hematol. 2026 Jun 02. PMID: 42227164.

Published on 5/18/2026

He T, Zheng C, La J, Pham D, Jafari O, Strampe J, Dulberger K, Ramos-Cejudo J, Gaziano JM, Do NV, Chitalia V, Ravid K, Li A, Fillmore NR. A deep learning model to dynamically predict cancer-associated thromboembolism in large-scale healthcare systems. NPJ Digit Med. 2026 May 18. PMID: 42151458.

Published on 4/2/2026

Ryu J, La J, Patell R, Li A, Do N, Brophy M, Fillmore N, Zwicker JI. Survival assessment of warfarin and international normalized ratio exposure in cancer-associated venous thromboembolism: Veterans Affairs healthcare system-based analysis. Haematologica. 2026 Apr 02. PMID: 41924910.

Published on 3/30/2026

Goryachev SD, Wu JT, Lin E, Friedman DR, Zwolinski R, Dhond R, Elbers DC, La J, Yildirim C, Corrigan JK, Chen DCR, Brophy MT, Do NV, Fillmore NR. Rule-based natural language processing to extract clinical trial and research study enrollment history from unstructured notes. Health Informatics J. 2026; 32(1):14604582261430614. PMID: 41912375.

Published on 1/2/2026

Barata PC, Corrigan JK, La J, Culnan JM, Akama-Garren E, Dulberger KN, Dumontier C, Hansen J, Bihn JR, Bitting RL, Brophy MT, Cheng HH, Cooperberg MR, Do NV, Dorff T, Fojo AT, Gaziano JM, Goryachev SD, Halabi S, Hauger RL, Nanus DM, Rebbeck TR, Pan CX, Schoen MW, Swinnerton KN, Myrie K, Ramoni RB, Fillmore NR, Paller CJ, Rettig MB. Docetaxel Rechallenge vs Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer. JAMA Netw Open. 2026 Jan 02; 9(1):e2551231. PMID: 41543856.

Published on 1/1/2026

Cooperberg MR, Bihn JR, Culnan JM, La J, Goryachev SD, Chen DCR, Soloviev O, Lee G, Corrigan JK, Swinnerton KN, Nickols NG, Dulberger KN, Barata P, Bitting RL, Brophy MT, Cheng HH, De Hoedt A, Do NV, Freedland SJ, Garraway IP, Gaziano JM, Halabi S, Hauger RL, Loeb S, Nanus DM, Rebbeck TR, Rettig MB, Pan CX, Myrie K, Ramoni RB, Fillmore NR, Paller CJ. Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance. JAMA Oncol. 2026 Jan 01; 12(1):111-113. PMID: 41264314.

Published on 12/5/2025

Jose A, Lu S, Zhang C, La J, Young M, Gaziano JM, Fillmore NR, Ravid K, Chitalia VC. A panel of plasma proteins associated with venous thromboembolism in patients with prostate cancer. Cancer Biomark. 2025 Dec; 42(12):18758592251390251. PMID: 41348521.

Published on 11/3/2025

Li A, Jafari O, Lam BD, Jiang JY, Kim RB, Ma S, Zhou E, Tiong JW, Chiang EC, Ryu J, Amos CI, La J, Fillmore NR. Validation of a Risk Score for Cancer-Associated Thrombosis Using Nationwide EHR Data. JAMA Netw Open. 2025 Nov 03; 8(11):e2544428. PMID: 41288979.

Published on 10/14/2025

Lotfollahzadeh S, Jose A, Yang X, Bathla T, Lazowski A, Hoekstra I, Sethuraman K, Potluri S, Dulberger KN, La J, Fillmore NR, Piqueras MDC, Lee N, Cabral H, Ravid K, Chitalia VC. Dietary tryptophan augments cancer-associated venous thrombogenicity mitigated by indoleamine 2,3-dioxygenase 1 inhibition. Blood Adv. 2025 Oct 14; 9(19):4910-4923. PMID: 40668615.

Published on 9/1/2025

La J, Hshieh T, Hamparsumian A, Zwolinski R, Wood J, Dharne M, Gaziano JM, Brophy MT, Do NV, Munshi NC, Driver JA, Abel GA, Fillmore NR, DuMontier C. Potentially Inappropriate Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care System. J Natl Compr Canc Netw. 2025 Sep; 23(9):363-370. PMID: 40930142.